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Data from mouse models of the R403Q mutation in ␣-MHC, on the other hand, have provided more consistent findings. Myosin isolated from myocardium of ␣-MHC R403Q/R403Q homozygous mice demonstrate a marked enhancement of actinactivated ATPase, V actin , and stall force of V actin by ␣-actinin (7, 47) . Similarly, cardiac myosin isolated from ␣MHC R403Q/ϩ heterozygous mice shows enhanced ATPase (2, 31, 47) . Data from ATPase and V actin assays generally correspond to each other and reflect actomyosin cross-bridge kinetics (48) , whose enhancement in the R403Q myosin has been corroborated by a shorter cross-bridge time-on measured in the laser trap (47) .
Left ventricular (LV) function in the ␣MHC R403Q/ϩ heterozygous mouse, which mimics the human genotype leading to HCM, is characterized in part by an earlier and higher peak LV pressure and an elevated free wall fractional shortening compared with these measures in the wild-type mouse, ␣MHC ϩ/ϩ (11, 12, 24, 30, 43) . Furthermore, cardiac myocytes isolated from ␣MHC R403Q/ϩ mice demonstrated an enhanced unloaded shortening velocity, suggesting that myofilament mechanical performance may be enhanced (16) . These data from functionally intact myocardium imply a greater mechanical performance of the myocardial myofilaments containing the R403Q mutant ␣-MHC. Interestingly, only male (M) ␣MHC R403Q/ϩ mice develop HCM after 30 wk of age (11, 12, 24, 30, 43) , a condition that appears to underlie the greater likelihood for M mice to develop heart failure compared with that shown in female (F) mice (17, 18, 20, 24, 30, 42, 45) . Men carrying mutant alleles for sarcomeric proteins are likewise more likely than women to develop HCM (8, 22, 28, 49) . These findings suggest that the sarcomeric incorporation of R403Q mutant myosin affects myofilament performance significantly enough in M to initiate the development of HCM but is relatively inconsequential to myofilament performance in F. Myofilament tension development and Ca 2ϩ sensitivity of tension development, however, were not found to be significantly altered in the M-␣MHC R403Q/ϩ group (2, 31) . Other important physiological measures of myofilament mechanical performance, namely shortening velocity and power production, have not yet been reported in the ␣MHC R403Q/ϩ of either sex. It has already been observed that cardiac contractile function and contractile reserve are enhanced in male compared with female animals (34, 38, 39) . Gonadectomy in rats of either sex leads to a significantly reduced myosin ATPase consistent with the concomitant ϳ30 -40% reduction in ␣-MHC (3, 38, 39, 52) . Testosterone recovers cardiac function in gonectomized rats of either sex (39) , whereas estrogen reduces myofilament sensitivity to Ca 2ϩ activation (4, 46, 52) . Collectively, these observations imply that the sarcomeric incorporation of a differently performing myosin, such as the R403Q mutant ␣MHC, would modify myofilament performance and, in addition, in a sex-dependent manner.
In the present study, we sought to determine the fundamental myofilament basis for sex differences in the hypertrophic response due to the R403Q mutant myosin. We directly tested the hypothesis that several indexes of myofilament mechanical performance (namely, tension development, Ca 2ϩ sensitivity, frequency of oscillatory work production, shortening velocity, and power production) would be different between M-and F-␣MHC R403Q/ϩ myocardium. We found that myofilament performance in both M-␣MHC R403Q/ϩ and F-␣MHC R403Q/ϩ mice was significantly enhanced compared with sex-matched ␣MHC ϩ/ϩ mice. However, there were no sex differences in ␣MHC R403Q/ϩ myofilament performance, which could account for the sex differences in the development of HCM.
METHODS
All procedures were similar to those described previously (2, 31) and were reviewed and approved by the Harvard University and University of Vermont Institutional Animal Care and Use Committees. All reagents were purchased from Sigma (St. Louis, MO), except where noted.
Mice undergoing echocardiography at 40 wk. Heterozygous ␣MHC R403Q/ϩ mice and ␣MHC ϩ/ϩ littermate controls of 129SvEv background (40 wk old) underwent transthoracic echocardiography as described previously (24) using a Sonos 5500 ultrasonograph (Hewlett-Packard, Andover, MA) and a 12-MHz focused transducer. Mice received 2.5% Avertin and were warmed with a heating pad during the procedure. Standard measures of LV wall and chamber dimensions and fractional shortening were obtained as described previously (10, 24) .
Solutions for skinned myocardial strips. Solutions were formulated by solving equations describing ionic equilibria (14) . Relaxing solution (pCa 8) contained 5 mM EGTA, 5 mM ATP, 1 mM Mg 2ϩ , 240 U/ml creatine kinase, 40 mM phosphocreatine, and 190 meq ionic strength (pH 7.0). Activation solution was same as relaxing solution but with pCa 4. Rigor solution was same as activating but without ATP, creatine kinase, and phosphocreatine. Storage solution was same as relaxing but with 10 g/ml leupeptin and 50% wt/vol glycerol. Skinning solution was same as storage but with 1% vol/vol Triton X-100.
Analyses for cardiac sarcomere performance in mice at 10 -20 wk. ␣MHC R403Q/ϩ and ␣MHC ϩ/ϩ mice aged 10 -20 wk were acquired from the laboratory of Dr. J. G. Seidman. Mice were killed by cervical dislocation, and hearts were rapidly excised and placed in 95% O2-5% CO2 bubbled Krebs solution containing 30 mM 2,3-butanedione monoxime (26) . Right ventricles were trimmed away, and LV papillary muscles were removed. Papillary muscles were dissected to yield at least four thin strips (ϳ120 -160 m diameter, ϳ800 m length) with longitudinally oriented parallel fibers as described previously (26) . The strips were chemically skinned for 2 h at room temperature and stored at Ϫ20°C for no more than 7 days. At the time of study, aluminum T-clips were attached to the ends of a strip ϳ200 m apart. The strip was mounted between a piezoelectric motor (Physik Instrumente, Auburn, MA) and a strain gauge (SensorNor, Horten, Norway), lowered into a 30-l droplet of relaxing solution maintained at 37°C, and incrementally stretched to and maintained at 2.2-m sarcomere length detected by videography and digital Fourier transform techniques (IonOptix, Milton, MA). HPRT1, hypoxanthine guanine phosphoribosyl transferase 1; NPPA, natriuretic polypeptide A; NPPB, natriuretic polypeptide B; ACTA1, skeletal actin; TNNT2, cardiac troponin T; TNNI3, cardiac troponin I. Table 2 . Mouse heart characteristics at age 40 wk measured by echocardiography At least two strips from each heart were Ca 2ϩ activated from pCa 8.0 to pCa 4.5. At each pCa point, strips underwent sinusoidal length perturbations of amplitude 0.125% strip length and over frequencies ranging between 0.125 and 250 Hz as previously described (2, 31 At maximum Ca 2ϩ activation, pCa 4.5, strips underwent one of two different additional protocols: 1) temperature was reduced to 27°C and slack test was applied to determine unloaded shortening velocity Vslack (32), or 2) temperature was reduced to 17°C and a force-clamp protocol was executed to acquire the force-velocity relationship. These reductions in temperature slowed kinetics sufficiently to affect accurate recording of respective measures.
Individual recordings of force-velocity relationship were fit to the hyperbolic Hill equation:
, where a and b are fitted parameters, Tmax ϭ measured maximum activated tension, T/T max ϭ prescribed tension for force clamp as fraction of T max, and V ϭ recorded velocity at T/Tmax (15) . Characteristics of mechanical power (P) were calculated as follows:
, and maximum power (P max) ϭ VoptTopt/Tmax (in ML/s ϫ T/T max) (15) .
Two additional strips from each heart were maximally activated with pCa 4.5, exposed to P i concentrations of 0.0, 0.25, 0.5, and 1.0 mM, and examined by sinusoidal length perturbations (2, 31) .
Cardiac myosin isoform distribution. Approximately 10 mg of ventricular tissue were homogenized in buffer containing (in mM) 300 KCl, 150 KH2PO4, 20 NaP2O7, 10 MgCl , 5 DTT, and 2 ATP (pH 6.8). Myosin was extracted in the above buffer for 1 h on ice with gentle agitation and then clarified with centrifugation (14,0000 g ϫ 1 min). The protein concentration of the resulting supernatant was determined by Bio-Rad protein assay (Bio-Rad, Hercules, CA). Myosin isoform separation was achieved by the method of Reiser and Kline (27, 35) . In brief, isolated cardiac myosin (2-5 g) was run on separating gels (contain 8% acrylamide and 5% glycerol) for 30 h at Gene expression of natriuretic polypeptide B (NPPB), skeletal actin (ACTA1), cardiac troponin T (TNNT2), and cardiac troponin I (TNNI3) were not significantly affected by the R403Q allele. MHC, myosin heavy chain. *Different from sex-matched ␣MHC ϩ/ϩ mice (P Ͻ 0.05).
Fig. 2. Myofilament protein analysis.
A: SDS-PAGE gel electrophoresis of myosin from ␣MHC R403Q/ϩ and ␣MHC ϩ/ϩ mouse hearts. The separation of ␣-MHC from ␤-MHC was verified in far left lane, which contained a mixture from bovine heart. All other lanes are marked by sex and genotype. No proportion of ␤-MHC was detected in any of the mouse hearts. B and C: relative protein levels for TNNT2 and TNNI3 were not significantly affected by R403Q allele or by sex. The level of TNNI3 phosphorylation (TNNI3-P) was reduced in the both males and females carrying the R403Q allele. Similar levels of GAPDH indicate similar protein loads. *Different from sex-matched ␣MHC ϩ/ϩ mice (P Ͻ 0.05).
200 V and 8°C. After silver staining, relative isoform content was determined by densitometric analysis with the Fluormax-2 imaging analysis system (Bio-Rad). Separation of ␣-MHC and ␤-MHC was verified with bovine cardiac myosin.
Cardiac quantitative real-time PCR analysis. Heterozygous ␣-MHC
R403/ϩ (2 M and 2 F) and ␣MHC ϩ/ϩ (7 M and 7 F) mice at 7-18 wk of age were killed by cervical dislocation. Cardiac ventricles were immediately harvested. The total RNA isolation was prepared from the ventricular tissue of each mouse separately using TRIzol reagent (Invitrogen, Carlsbad, CA).
Reverse transcription of total RNA (2 g) was carried out by random hexamer primers and MultiScribe reverse transcriptase from high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). The cDNA from tissue samples of different mice was used as a template for each replicate in each experiment. The specific oligonucleotide primers were designed using Primer3 (http:// frodo.wi.mit.edu/) or retrieved from Primer Bank (http://pga.mgh. harvard.edu/primerbank/) (Table 1) (37, 50) . The 15-l PCR reaction performed by 7500 fast real-time PCR system (Applied Biosystems) contained Power SYBR green PCR master mix (Applied Biosystems), 7.5 pmol of each primer, and 1 l of cDNA template. The relative levels of mRNA expression normalized to control hypoxanthine guanine phosphoribosyl transferase 1 were calculated according to the ⌬⌬C T method. Dissociation curve analysis was performed after each complete PCR to confirm an expected DNA product.
Western blot analysis. Tissue samples were also separately homogenized with tissue homogenizer in lysis buffer (50 mM Tris ⅐ HCl, 150 mM NaCl, 0.25% deoxycholic acid, 1% Nonidet P-40, 1 mM EDTA, pH 7.4, and 0.1% SDS) containing protease inhibitor cocktail (Roche, Indianapolis, IN) and phosphatase inhibitor cocktail (Pierce, Rockford, IL). Protein concentration was determined using bicinchoninic acid protein assay (Pierce).
Protein extracts were subjected to reducing SDS-PAGE and transferred to polyvinylidene difluoride membrane. Mouse monoclonal cardiac troponin T antibody (1:1,000; ab8295, Abcam, Cambridge, MA) and rabbit anti-troponin I polyclonal antibody (1:1,000; no. 4002; Cell Signaling, Danvers, MA) were used as primary antibody to detect 20 g of cardiac troponin T and cardiac troponin I, respectively. Rabbit anti-phospho-troponin I polyclonal antibody (1:1,000; no. 4004, Cell Signaling) was used to detect 60 -80 g of phosphorylated cardiac troponin I. All secondary antibodies (1:5,000; Santa Cruz, Santa Cruz, CA) were horseradish peroxidase conjugated. Rabbit anti-GAPDH polyclonal antibody (1:10,000; ab36840, Abcam) was used as internal control to normalize the amount of proteins among Western blots. The detection of horseradish peroxidase was performed using SuperSignal West Pico chemiluminescent substrate (Pierce). Autoradiograph was developed using BioMax light film (Kodak, Rochester, NY). The band intensities of protein levels were quantified by densitometry with National Institutes of Health Image J software (http://rsb.info.nih.gov/ij/) (1).
Statistical analysis. All data are presented as means Ϯ SE. Multiple measures from a single heart were averaged together to provide a single value for that heart. Two-way ANOVA was performed using sex (M, F) and R403Q mutation (␣MHC ϩ/ϩ , ␣MHC . Analysis was performed using SPSS 10.0. Statistical significances are reported at the P Ͻ 0.05 and P Ͻ 0.01 levels.
RESULTS
Hypertrophic response and gene expression. The development of HCM, as indicated by thicker LV posterior wall and narrower LV chamber dimensions (Table 2) , was significant in the M-␣MHC R403Q/ϩ but not in the F-␣MHC R403Q/ϩ mice at age 40 wk. Fractional shortening was also significantly elevated in the M-␣MHC R403Q/ϩ but not in the F-␣MHC R403Q/ϩ mice ( Table 2 ). These data are consistent with previous findings of enhanced LV performance and thicker LV walls in the M-␣MHC R403Q/ϩ and relatively normal LV performance and wall thickness in F-␣MHC R403Q/ϩ mice (13, 29) . Fig. 3 . Characteristics of isometric tension-pCa relationships. A and B: myofilaments of ␣MHC R403Q/ϩ mice showed no significant differences in the sensitivity to Ca 2ϩ activation compared with sex-matched ␣MHC ϩ/ϩ . C: maximum activated tension (Tmax) was elevated in both M-and F-␣MHC R403Q/ϩ mice compared with that shown in ␣MHC ϩ/ϩ , as detected by a significant mutation effect of ANOVA (P Ͻ 0.05). D: significant mutation ϫ Pi interaction for Tmax indicated that ␣MHC R403Q/ϩ group is more sensitive to the reduction with tension as occurs with Pi exposure. Number of mice were 9 M-␣MHC ϩ/ϩ , 6 M-␣MHC R403Q/ϩ , 10 F-␣MHC ϩ/ϩ , and 6 F-␣MHC R403Q/ϩ . 
Gene expression of natriuretic polypeptide A measured by RT-PCR was elevated in the hearts of both M-and F-␣MHC
R403Q/ϩ mice at 7-18 wk compared with sex-matched controls (Fig. 1) . Gene expression levels of natriuretic polypeptide B, skeletal actin, cardiac troponin T, and cardiac troponin I were not significantly affected by the R403Q allele (Fig. 1) . The similar gene expression profiles observed between the male and female mice indicated a similar hypertrophic response of the cardiac tissue initiated in both males and females. Nevertheless, sex differences in LV performance and HCM development in the ␣MHC R403Q/ϩ genotype may indicate sex differences in the mechanical performance of the R403Q myosin incorporated into the myofilaments. We therefore tested whether myofilament protein characteristics and performance in the ␣MHC R403Q/ϩ mice were differentiated between M and F animals at an earlier age and accordingly could be responsible for the sex differences in the development of HCM.
Myofilament protein characteristics. Cardiac myosin in all four groups at age 10 -20 wk was composed of ␣-MHC and did not include any detectable portion of ␤-MHC (Fig. 2A) . Therefore, measures of myofilament mechanical performance cannot be due to the incorporation of ␤-MHC. It has been reported previously that ϳ50% of the myosin is the R403Q mutant (12, 24) .
The phosphorylation status of troponin I was reduced in both F-and M-␣MHC R403Q/ϩ mice (Fig. 2, B and C) . Any differences in sarcomere performance observed between ␣MHC R403Q/ϩ and ␣MHC ϩ/ϩ could therefore not be attributed to troponin I phosphorylation.
Isometric tension-pCa and tension-P i relationships at 10 -20 wk. The Ca 2ϩ sensitivity of myofilament activation was not different between M-␣MHC R403Q/ϩ and M-␣MHC ϩ/ϩ mice (Fig. 3A) or between F-␣MHC R403Q/ϩ and F-␣MHC ϩ/ϩ mice (Fig. 3B) . However, myofilaments from M mice of either genotype were significantly more sensitive to Ca 2ϩ activation than those of F mice (sex main effect P Ͻ 0.05; Table 3 ). This result highlights a sex difference in this particularly important . Maximum work production and frequency of maximum work production in cardiac myofilaments. A and B: maximum work production rose with Ca 2ϩ activation in all populations. Interestingly, at the lowest Ca 2ϩ activation, maximum work was higher in both M-and F-␣MHC R403Q/ϩ than in M and F controls. C and D: frequency of maximum work production was reduced with Ca 2ϩ activation, and at maximum Ca 2ϩ activation was significantly higher in the M-and F-␣MHC R403Q/ϩ than in M and F controls. E and F: frequency of maximum work production was elevated with increasing concentrations of Pi (P Ͻ 0.05 for Pi main effect). The myosin with the R403Q mutation was more sensitive to Pi, as indicated by a significant mutation ϫ Pi interaction. *Different from sex-matched ␣MHC ϩ/ϩ mice (P Ͻ 0.05).
physiological attribute of myofilament activation and relaxation, which may contribute to the sex differences in the development of the HCM phenotype. There was a statistically significant elevation in T max in the ␣MHC R403Q/ϩ mice by ϳ10% compared with ␣MHC ϩ/ϩ , as indicated by a significant mutation main effect (P Ͻ 0.05; Fig. 3C ). Marginal trends for an elevation in T max were observed previously for the ␣MHC R403Q/ϩ mice but were without statistical significance (2, 31). There was also a significant mutation ϫ P i interaction for T max (P Ͻ 0.05), indicating that ␣MHC R403Q/ϩ group is more sensitive to the reduction with tension as occurs with P i exposure. This result can be visualized in Fig. 3D , where the recorded tension in both the M-and F-␣MHC R403Q/ϩ populations was diminished by P i with a greater sensitivity than in the sex-matched ␣MHC R403Q/ϩ mice. Sinusoidal length perturbations and oscillatory work. Sinusoidal length perturbations were normalized by the muscle length providing a strain on the activated myofilaments. An example of a single cycle of sinusoidal strain is illustrated as the dotted line in Fig. 4A . The resultant stress, which is the sinusoidal change from steady-state tension, will lag behind the strain, illustrated by the example at 9 Hz in Fig. 4A , or will lead the strain, illustrated by the example at 15 Hz in Fig. 4A .
The work loops presented in the stress-strain relationships of Fig. 4B indicate the amount of work that is generated by the myofilaments (i.e., when loop is counterclockwise, work is positive) or is absorbed by the myofilaments (i.e., when loop is clockwise, work is negative). At maximum Ca 2ϩ activation, work was generated at a higher frequency range in M-␣MHC R403Q/ϩ mice than in M-␣MHC ϩ/ϩ mice ( Fig.  4C ) and also for F-␣MHC R403Q/ϩ mice vs. F-␣MHC ϩ/ϩ mice (Fig. 4D) .
The maximum work produced during sinusoidal length perturbation of activated myofilaments was higher in the ␣MHC R403Q/ϩ mice than in sex-matched ␣MHC ϩ/ϩ mice (Fig. 5, A and B ) when myofilaments were exposed to pCa 7 or pCa 8 and therefore not Ca 2ϩ activated. These data indicate that there must have been an enhanced Ca 2ϩ -independent activation of the thin filament in the ␣MHC R403Q/ϩ mice compared with sex-matched ␣MHC ϩ/ϩ Tension-velocity and power-velocity relationships were measured using force-clamp technique. A: several predefined fractions of maximum absolute tension are used as the target tensions for feedback control of the length motor. Steady-state tension occurs within ϳ100 ms. B: velocity of shortening required to achieve target tension is calculated as the slope of the muscle length after 200 ms. C: in both M and F mice, myofilaments of ␣MHC R403Q/ϩ were capable of shortening with higher velocities at all imposed mechanical loads compared with sex-matched ␣MHC ϩ/ϩ mice. D: mechanical power output was significantly higher in the ␣MHC R403Q/ϩ myofilaments than in sex-matched ␣MHC ϩ/ϩ over the entire range of mechanical loads. *Different from sex-matched ␣MHC ϩ/ϩ (P Ͻ 0.05). †Different from M-␣MHC ϩ/ϩ (P Ͻ 0.05).
mice. However, when the thin filament was Ca 2ϩ activated, work production rose with the degree of Ca 2ϩ activation but also similarly between ␣MHC R403Q/ϩ and sex-matched ␣MHC ϩ/ϩ mice (Fig. 5, A and B) . At or near maximum Ca 2ϩ activation, the frequency of maximum work production was significantly higher in the ␣MHC R403Q/ϩ mice than in sex-matched ␣MHC ϩ/ϩ mice (Fig.  5, C and D) . The frequency of maximum work production also rose with P i concentration (Fig. 5 , E and F) as indicated by a significant P i main effect (P Ͻ 0.05). Additionally, there was a significant mutation main effect and mutation ϫ P i interaction (P Ͻ 0.05). These latter results can be visualized in Fig. 5 , E and F, as a higher frequency of maximum work and a greater P i sensitivity of the frequency of maximum work in the ␣MHC R403Q/ϩ compared with sex-matched ␣MHC ϩ/ϩ mice. There were no mutation ϫ sex or mutation ϫ sex ϫ P i interactions.
V slack and force-velocity relationships. Maximum V slack , measured by the slack test, was elevated in F compared with M mice (sex main effect P Ͻ 0.05) and in ␣MHC R403Q/ϩ compared with ␣MHC ϩ/ϩ mice (genotype main effect P Ͻ 0.05) (Fig. 6, A and B) . By post hoc analysis, V slack in M-␣MHC ϩ/ϩ mice was significantly lower than that shown in the other groups (Fig. 6, C and D) . The higher V slack due to the R403Q mutation is consistent with the finding of higher actin velocities in motility assays using R403Q myosin isolated from homozygous or heterozygous mice (47) . Figure 7 , A and B, demonstrates the force-clamp method used to assay the tension-velocity relationships. Figure 7 , C and D, illustrates the resulting tension-velocity relationships. Velocity of shortening at all loads was elevated in the ␣MHC R403Q/ϩ muscle strips compared with sex-matched ␣MHC ϩ/ϩ mice. Correspondingly, mechanical power output at all loads was higher in the ␣MHC R403Q/ϩ muscle strips of both M and F animals (Fig. 7, C and D) . Table 4 provides values for hyperbolic Hill characteristics of the tension-velocity and tension-power relationships for the four mouse populations. The curvature of the tension-velocity relationships was suppressed in the ␣MHC R403Q/ϩ mice, as indicated by the elevated values for a/T max (Table 4 ) and as can be seen in Fig. 7, C and D (15) . The extrapolated value of V max was not significantly different due to sex or R403Q mutation. However, the directly measured loaded shortening under all loaded conditions, including the lowest load of only 4% T max , was significantly higher in M-and F-␣MHC R403Q/ϩ than in Mand F-␣MHC ϩ/ϩ (Fig. 7, C and D) . V opt is the velocity of shortening at P max output and was significantly higher in the ␣MHC R403Q/ϩ mice, independent of sex (genotype main effect P Ͻ 0.05; Table 4 ).
The relative tension at P max output (T opt /T max ) was higher in M-than in F-␣MHC R403Q/ϩ mice (Table 4) . This is an important result because it suggests that M sex and the R403Q mutation independently promote myofilament performance to achieve higher power output at higher mechanical loads than in ␣MHC ϩ/ϩ . P max was likewise higher in M and in ␣MHC R403Q/ϩ mice. Interestingly, T opt /T max and P max were similar between M-␣MHC R403Q/ϩ and F-␣MHC R403Q/ϩ mice, indicating that sex played no role in determining these measures of enhanced myofilament performance due to R403Q mutation.
Sex hormones and HCM development. To explore the influence of sex hormones on HCM development and LV function, we removed the gonads of a small number of mice and measured LV dimensions and function via echocardiography. Interestingly, thickening of the LV wall was diminished or nonexistent in the castrated M-␣MHC R403Q/ϩ compared with M-␣MHC ϩ/ϩ mice, but LV wall was thicker in the oopherectomized F-␣MHC R403Q/ϩ than in F-␣MHC ϩ/ϩ mice (Table 5 ). In addition, LV fractional shortening was similarly enhanced in M-␣MHC R403Q/ϩ and F-␣MHC R403Q/ϩ mice compared with sex-matched ␣MHC ϩ/ϩ mice (Table 5) , in contrast to the lack of enhanced fractional shortening observed in F-␣MHC R403Q/ϩ mice with intact sex hormones ( Table 2) . We did not at this time undertake the analysis of myofilament performance in the gonadectomized populations. Values are means Ϯ SE. Tmax, maximum activated tension; Vopt, velocity at maximum power; a and b, fitted parameters; Pmax, maximum power; ML, muscle length.
s Sex main effect (P Ͻ 0.05); m R403Q mutation main effect (P Ͻ 0.01). Post hoc differences were significant by Duncan's test. *Different from sex-matched ␣MHC ϩ/ϩ mice (P Ͻ 0.05). †Different from M-␣MHC ϩ/ϩ mice (P Ͻ 0.05).
DISCUSSION
We report here that sex differences in the development of HCM due to the incorporation of the R403Q mutant myosin are not due to sex differences in the underlying myofilament performance. Relative to sex-matched ␣MHC ϩ/ϩ mice, we found that cardiac myofilaments of the ␣MHC R403Q/ϩ mice had a higher T max (Fig. 3C) , a higher frequency of maximum work (Fig. 5, C and D) , a higher sensitivity of tension and frequency of maximum work to P i (Figs. 3D and 5, E and F) , a higher V slack (Fig. 6D) , a higher shortening velocity at nearly all mechanical loads (Fig. 7C) , and a higher mechanical power output at nearly all mechanical loads (Fig. 7D and Table 4 ). These attributes, measured at the level of the skinned myocardial strip, strongly suggest an elevation in myofilament kinetic and mechanical performance due to the R403Q mutant myosin (7, 33, 47) .
Interestingly, these measures of the enhanced myofilament performance due to the R403Q mutation were independent of sex, although sex played a separate and significant role in affecting some measures of myofilament performance. Specifically, F sex was associated with a lower myofilament sensitivity to Ca 2ϩ activation (Fig. 3A) , consistent with previous reports of enhanced myofilament Ca 2ϩ sensitivity in overectomized F rats (4, 46, 52) . F sex was also associated with a higher V slack , as measured by the slack test (Fig. 6D) . The underlying mechanisms, however, are not clear, although our data (Fig. 2) suggest that myosin isoform profile and troponin I phosphorylation were not contributing factors. Myofilament kinetics, characterized here by the frequency of oscillatory work, were not significantly elevated in the F-␣MHC ϩ/ϩ compared with M-␣MHC ϩ/ϩ mice and were not more sensitive to P i and therefore could not explain the higher unloaded velocity in the F-␣MHC ϩ/ϩ mice. Measures of myofilament velocity and power underloaded conditions, however, were significantly more sensitive to load in the F-␣MHC ϩ/ϩ mice, as indicated by the lowest measures of the parameter a/T max (Table 4) (15) . Additionally, P max production occurred at lower tensions in the F-␣MHC ϩ/ϩ animals (e.g., T opt in Table 4 ). Thus we speculate that those molecular mechanisms responsible for the load sensitivity of myofilament shortening velocity and power production underlie the greater V slack and lower T opt results in the F-␣MHC ϩ/ϩ mice. At this time, it is not clear what these molecular mechanisms may be, although an upregulation of the atrial myosin essential light-chain isoform and/or an elevated level regulatory light-chain phosphorylation represent two possible mechanisms at the myofilament level (6, 25) . M sex was associated with a higher shortening velocity (Fig. 7C ) and power production ( Fig. 7D and Table 4 ) under all loaded conditions. These results imply that myofilament performance contributes substantially to the enhanced cardiac contractile function in the LV of males compared with females (38) .
The higher frequency of maximum work, force production, V opt , and P max in the ␣MHC R403Q/ϩ mice at the myofilament level mimic and likely underlie the enhanced systolic elastance (13) , rate of pressure development (29) , and circumferential fractional shortening (24, 42) observed for LV function in the M-␣MHC R403Q/ϩ mice ( Table 2) . One detrimental effect of the enhanced power generation by the R403Q mutant ␣-MHC in the M-␣MHC R403Q/ϩ mice could be the mechanical disruption of intersarcomeric and intermyocyte connections, as indicated by the loss of Z-line registration and by the development of myocyte disarray and fibrosis (24, 40, 47) .
As stated above, the enhanced characteristics of myofilament performance measured here were independent of sex, whereas enhanced LV systolic performance was not observed in the F-␣MHC R403Q/ϩ mice ( Table 2 ). These observations suggest that F sex hormones neutralize the intrinsically enhanced myofilament performance of the F-␣MHC R403Q/ϩ mice in vivo. Indeed, we found that gonadectomized ␣MHC R403Q/ϩ mice exhibit similarly narrowed chamber dimensions and enhanced fractional shortening in both sexes (Table 5 ). These data would imply that the development of HCM due to a R403Q mutant allele may be accelerated by M sex hormones, as suggested by others (21, 23) , and/or by the absence of F sex hormones (3, 21, 46) .
